Class of 2003: Henry Rogers

MBiotech Class of 2003: Henry Rogers
Investment Advisor at BMO Nesbitt Burns

When Henry graduated, he had already secured a full-time position at Apotex in their Innovative Drug Development (IDD) group as a Marketing Associate. He spent a lot of my time working with the sales and marketing teams in other countries, forecasting, writing business plans, product website (content development and design). He travelled to attend conferences where his company was one of the main sponsors (Bali, Cyprus, Sicily) connecting with key opinion leaders (haematologists).  After working at IDD for about 4 years, Henry worked as a sales representative at Pfizer. Planning how he would deliver his message was a critical part of this role and he learned a lot about selling and influencing behaviour while he was at Pfizer. 

In 2007 Henry joined Nesbitt Burns and has been building his business since then. As Investment Advisor, he manages $35 million dollars for about 50 different clients (individuals and families, some corporations). 

The Biotech Program developed his intellectual capacity and organizational skills tremendously. He learnt some critical thinking skills, was able to problem solve and work effectively in teams. Henry mentions that he will never forget when Paul Horgen, Director of the MBiotech Program at the time, told a group that had just presented their project to the class that it was "undergraduate quality". It was a running joke amongst the class but it highlighted the objective of the Director which was to produce a high quality individual, with the capacity to be able to impact an organization immediately.  Henry says, “The program also opened doors through the co-op program, I cannot assign a value to that aspect of the program because it sent me on the path that ultimately lead me to where I am today, it may be the most important part.”